Blue Jet Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2025.
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Blue Jet Healthcare's board approved several routine governance items on August 22, 2025. M/s. Mehta & Mehta has been appointed as Secretarial Auditor for a 5-year term starting FY 2025-26, pending shareholder approval. Mr. Naresh Suryakant Shah has been re-appointed as Whole-Time Director for 5 years effective December 31, 2025, and Mr. Popat Bhagwan Kedar has been re-designated as Whole-Time Director for 5 years effective September 26, 2025. The board fixed September 19, 2025 as the record date for a final dividend of Rs. 1.2 per share (60%) on shares of Rs. 2 face value for FY 2024-25, to be paid by October 25, 2025. The 57th Annual General Meeting is scheduled for September 26, 2025 via video conferencing.
These are routine board-level approvals with no negative surprises — no resignations, no governance red flags, and continuity in leadership with re-appointments of existing whole-time directors. The Rs. 1.2 per share final dividend rewards shareholders, and the record date of September 19, 2025 is the key date for investors to be eligible. Stock price impact is expected to be neutral.